Orphenadrine
- Generic Name
- Orphenadrine
- Brand Names
- Norgesic, Norgesic Forte, Orfenace, Orphengesic
- Drug Type
- Small Molecule
- Chemical Formula
- C18H23NO
- CAS Number
- 83-98-7
- Unique Ingredient Identifier
- AL805O9OG9
- Background
A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
- Indication
用于治疗帕金森病和吩噻嗪类药物引起的锥体外系症状，但对迟发性运动障碍无效。用于治疗急性肌骨骼疼痛
- Associated Conditions
- Back Pain Lower Back, Fever, Menstrual Distress (Dysmenorrhea), Mild pain, Muscle Spasms, Mild Musculoskeletal Disorder, Mild to moderate pain, Moderate Musculoskeletal Disorder, Moderate Pain
- Associated Therapies
- -
Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery
Phase 4
Completed
- Conditions
- Pain ManagementPosterior Spinal Fusion
- Interventions
- First Posted Date
- 2022-06-10
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- University of Puerto Rico
- Target Recruit Count
- 100
- Registration Number
- NCT05413902
- Locations
- 🇵🇷
Puerto Rico Medical Center - University District Hospital, San Juan, Puerto Rico
Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 5
- Registration Number
- NCT04509336
- Locations
- 🇪🇬
Tanta University Hospitals, Tanta, Egypt
Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery
Phase 4
- Conditions
- IleusColon CancerIleus; MechanicalConstipation Drug InducedColon DiverticulosisColonic NeoplasmsPain, PostoperativeIleus ParalyticColonic DiverticulitisConstipation
- Interventions
- Drug: Morphine SulfateDrug: AcetaminophenDrug: FentanylDrug: GabapentinDrug: OrphenadrineDrug: HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLETDrug: LidocaineDrug: MarcaineDrug: KetamineDrug: MethadoneDrug: TramadolDrug: KetorolacDrug: DilaudidDrug: Hydrocodone-Acetaminophen Tab 5-325 MG
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2017-03-20
- Lead Sponsor
- University of Illinois College of Medicine at Peoria
- Target Recruit Count
- 80
- Registration Number
- NCT02958566
- Locations
- 🇺🇸
Uicomp, Peoria, Illinois, United States
Orphenadrine and Methocarbamol for LBP
Phase 4
Completed
- Conditions
- Low Back Pain
- Interventions
- First Posted Date
- 2016-01-27
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 240
- Registration Number
- NCT02665286
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
- First Posted Date
- 2015-04-22
- Last Posted Date
- 2019-06-07
- Lead Sponsor
- Sherief Abd-Elsalam
- Target Recruit Count
- 100
- Registration Number
- NCT02423395
- Locations
- 🇪🇬
Tanta university hospital, Tanta, Egypt
Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients
Not Applicable
Withdrawn
- Conditions
- Pain Relief
- Interventions
- First Posted Date
- 2010-12-21
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Western Galilee Hospital-Nahariya
- Registration Number
- NCT01263652
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath